Stoke Therapeutics, Inc. Contracts & Agreements

Separation and Release Agreement, by and between the Registrant and Stephen J. Tulipano, dated May 2, 2024 (Filed With SEC on August 7, 2024)

Change of Control Severance Agreement, by and between the Registrant and Thomas Leggett, effective as of April 23, 2024 (Filed With SEC on August 7, 2024)

Executive Employment Agreement, by and between the Registrant and Thomas Leggett, effective as of April 23, 2024 (Filed With SEC on August 7, 2024)

Form of Pre-Funded Warrant (Filed With SEC on March 28, 2024)

Underwriting Agreement dated March 27, 2024, by and between the Company and J.P. Morgan Securities LLC (Filed With SEC on March 28, 2024)

Lease Agreement, dated as of September 8, 2021, by and between ARE-MA Region No. 24, LLC and the Registrant, as amended to date (Filed With SEC on March 25, 2024)

Description of Common Stock Registered Under Section 12 of the Securities Exchange Act of 1934 (Filed With SEC on March 25, 2024)

2019 Equity Incentive Plan, and forms of award agreements (Filed With SEC on March 6, 2023)

Scientific Advisory Board Agreement by and between Adrian Krainer, Ph.D. and the Registrant, dated June 1, 2022 (Filed With SEC on August 8, 2022)

Scientific Advisory Board Agreement by and between the Registrant and Adrian Krainer, Ph.D., dated June 1, 2021 (Filed With SEC on March 10, 2022)

Amendment to Sublease dated as of September 8, 2021, by and between Homology Medicines, Inc., and the Registrant (Filed With SEC on November 8, 2021)

Lease Agreement dated as of September 8, 2021, by and between ARE-MA Region No. 24, LLC, and the Registrant (Filed With SEC on November 8, 2021)

Amended and Restated Executive Employment Agreement, by and between the Registrant and Barry Ticho, effective as of October 21, 2020 (Filed With SEC on March 9, 2021)

Change of Control and Severance Agreement, by and between the Registrant and Barry Ticho, effective as of October 21, 2020 (Filed With SEC on March 9, 2021)

Description of Common Stock Registered Under Section 12 of the Securities Exchange Act of 1934 (Filed With SEC on March 9, 2021)

Underwriting Agreement dated November 19, 2020 (Filed With SEC on November 20, 2020)

Amended and Restated Executive Employment Agreement, by and between the Registrant and Edward M. Kaye, effective as of October 21, 2020 (Filed With SEC on November 12, 2020)

Change of Control and Severance Agreement, by and between the Registrant and Robin Walker, effective as of October 21, 2020 (Filed With SEC on November 12, 2020)

Change of Control and Severance Agreement, by and between the Registrant and Stephen J. Tulipano, effective as of October 21, 2020 (Filed With SEC on November 12, 2020)

Change of Control and Severance Agreement, by and between the Registrant and Edward M. Kaye, effective as of October 21, 2020 (Filed With SEC on November 12, 2020)

Amended and Restated Executive Employment Agreement, by and between the Registrant and Robin Walker, effective as of October 21, 2020 (Filed With SEC on November 12, 2020)

Amended and Restated Executive Employment Agreement, by and between the Registrant and Stephen J. Tulipano, effective as of October 21, 2020 (Filed With SEC on November 12, 2020)

Scientific Advisory Board Agreement, June 2020 (Filed With SEC on August 10, 2020)

Description of Common Stock Registered Under Section 12 of the Securities Exchange Act of 1934 (Filed With SEC on March 23, 2020)

License Agreement, dated July 31, 2015, by and between Cold Spring Harbor Laboratory and the Registrant (Filed With SEC on June 12, 2019)

License Agreement, dated April 18, 2016, by and between the University of Southampton and the Registrant (Filed With SEC on June 12, 2019)

Form of Common Stock Certificate (Filed With SEC on June 7, 2019)

Form of Underwriting Agreement (Filed With SEC on June 7, 2019)

Form of Indemnification Agreement with directors and officers (Filed With SEC on June 7, 2019)

2019 Equity Incentive Plan, to become effective on the date immediately prior to the date the registration statement is declared effective, and forms of award agreements (Filed With SEC on June 7, 2019)

2019 Employee Stock Purchase Plan, to become effective on the date the registration statement is declared effective, and forms of award agreements (Filed With SEC on June 7, 2019)

Employment Agreement, dated October 5, 2017, by and between the Registrant and Edward M. Kaye, as amended (Filed With SEC on May 23, 2019)

License Agreement, dated April 18, 2016, by and between the University of Southampton and the Registrant (Filed With SEC on May 23, 2019)

License Agreement, dated July 31, 2015, by and between Cold Spring Harbor Laboratory and the Registrant (Filed With SEC on May 23, 2019)

Lease Agreement, dated August 20, 2018, by and between Homology Medicines, Inc., and the Registrant (Filed With SEC on May 23, 2019)

2014 Equity Incentive Plan, as amended, and forms of award agreements (Filed With SEC on May 23, 2019)

Amended and Restated Investors Rights Agreement, dated October 22, 2018, by and among the Registrant and certain of its stockholders (Filed With SEC on May 23, 2019)

Employment Agreement, dated November 20, 2015, by and between the Registrant and Huw M. Nash (Filed With SEC on May 23, 2019)

Employment Agreement, dated September 8, 2017, by and between the Registrant and Barry J. Ticho, as amended (Filed With SEC on May 23, 2019)

Employment Agreement, dated January 7, 2018, by and between the Registrant and Gene Liau (Filed With SEC on May 23, 2019)

Employment Agreement, dated February 12, 2019, by and between the Registrant and Stephen J. Tulipano (Filed With SEC on May 23, 2019)

Consulting Agreement, dated October 24, 2014, by and between the Registrant and Adrian R. Krainer (Filed With SEC on May 23, 2019)

Lease Agreement dated January 2, 2019, by and between MIT 139 Main Street Leasehold LLC., and the Registrant (Filed With SEC on May 23, 2019)

Category

Industry

Companies

Contracts

Stoke Therapeutics, Inc. Contracts & Agreements